Neutralizing monoclonal antibodies to fight HIV-1 : on the threshold of success
- Autores
- Jaworski, Juan Pablo; Vendrell, Alejandrina; Chiavenna, Sebastián Matias
- Año de publicación
- 2017
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- Anti-human immunodeficiency virus type-1 (anti-HIV-1) neutralizing monoclonal antibodies are broadening the spectrum of pre- and post-exposure treatment against HIV-1. A better understanding of how these antibodies develop and interact with particular regions of the viral envelope protein is guiding a more rational structure-based immunogen design. The aim of this article is to review the most recent advances in the field, from the development of these particular antibodies during natural HIV-1 infection, to their role preventing infection, boosting endogenous immune responses and clearing both free viral particles and persistently infected cells.
Inst.de Virología
Fil: Jaworski, Juan Pablo. Instituto Nacional de Tecnología Agropecuaria (INTA). Instituto de Virología; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina
Fil: Vendrell, Alejandrina. Universidad de Buenos Aires. Facultad de Medicina. Centro de Estudios Farmacológicos y Botánicos; Argentina
Fil: Chiavenna, Sebastián Matias. Ferrer Advanced Biotherapeutics, Ferrer Internacional; España - Fuente
- Frontiers in immunology 7 : 661 (March 2017)
- Materia
-
Virus de la Inmunodeficiencia Humana
Anticuerpos Monoclonales
Profilaxis de las Enfermedades
Human Immunodeficiency Virus
Monoclonal Antibodies
Disease Prophylaxis - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- http://creativecommons.org/licenses/by-nc-sa/4.0/
- Repositorio
- Institución
- Instituto Nacional de Tecnología Agropecuaria
- OAI Identificador
- oai:localhost:20.500.12123/2005
Ver los metadatos del registro completo
id |
INTADig_7abe223cdfbaa53d3f26f88d72152e27 |
---|---|
oai_identifier_str |
oai:localhost:20.500.12123/2005 |
network_acronym_str |
INTADig |
repository_id_str |
l |
network_name_str |
INTA Digital (INTA) |
spelling |
Neutralizing monoclonal antibodies to fight HIV-1 : on the threshold of successJaworski, Juan PabloVendrell, AlejandrinaChiavenna, Sebastián MatiasVirus de la Inmunodeficiencia HumanaAnticuerpos MonoclonalesProfilaxis de las EnfermedadesHuman Immunodeficiency VirusMonoclonal AntibodiesDisease ProphylaxisAnti-human immunodeficiency virus type-1 (anti-HIV-1) neutralizing monoclonal antibodies are broadening the spectrum of pre- and post-exposure treatment against HIV-1. A better understanding of how these antibodies develop and interact with particular regions of the viral envelope protein is guiding a more rational structure-based immunogen design. The aim of this article is to review the most recent advances in the field, from the development of these particular antibodies during natural HIV-1 infection, to their role preventing infection, boosting endogenous immune responses and clearing both free viral particles and persistently infected cells.Inst.de VirologíaFil: Jaworski, Juan Pablo. Instituto Nacional de Tecnología Agropecuaria (INTA). Instituto de Virología; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; ArgentinaFil: Vendrell, Alejandrina. Universidad de Buenos Aires. Facultad de Medicina. Centro de Estudios Farmacológicos y Botánicos; ArgentinaFil: Chiavenna, Sebastián Matias. Ferrer Advanced Biotherapeutics, Ferrer Internacional; España2018-03-09T14:28:17Z2018-03-09T14:28:17Z2017info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfhttp://hdl.handle.net/20.500.12123/20051664-3224https://doi.org/10.3389/fimmu.2016.00661https://www.frontiersin.org/articles/10.3389/fimmu.2016.00661/fullFrontiers in immunology 7 : 661 (March 2017)reponame:INTA Digital (INTA)instname:Instituto Nacional de Tecnología Agropecuariaenginfo:eu-repo/semantics/openAccesshttp://creativecommons.org/licenses/by-nc-sa/4.0/Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0)2025-09-04T09:47:09Zoai:localhost:20.500.12123/2005instacron:INTAInstitucionalhttp://repositorio.inta.gob.ar/Organismo científico-tecnológicoNo correspondehttp://repositorio.inta.gob.ar/oai/requesttripaldi.nicolas@inta.gob.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:l2025-09-04 09:47:10.288INTA Digital (INTA) - Instituto Nacional de Tecnología Agropecuariafalse |
dc.title.none.fl_str_mv |
Neutralizing monoclonal antibodies to fight HIV-1 : on the threshold of success |
title |
Neutralizing monoclonal antibodies to fight HIV-1 : on the threshold of success |
spellingShingle |
Neutralizing monoclonal antibodies to fight HIV-1 : on the threshold of success Jaworski, Juan Pablo Virus de la Inmunodeficiencia Humana Anticuerpos Monoclonales Profilaxis de las Enfermedades Human Immunodeficiency Virus Monoclonal Antibodies Disease Prophylaxis |
title_short |
Neutralizing monoclonal antibodies to fight HIV-1 : on the threshold of success |
title_full |
Neutralizing monoclonal antibodies to fight HIV-1 : on the threshold of success |
title_fullStr |
Neutralizing monoclonal antibodies to fight HIV-1 : on the threshold of success |
title_full_unstemmed |
Neutralizing monoclonal antibodies to fight HIV-1 : on the threshold of success |
title_sort |
Neutralizing monoclonal antibodies to fight HIV-1 : on the threshold of success |
dc.creator.none.fl_str_mv |
Jaworski, Juan Pablo Vendrell, Alejandrina Chiavenna, Sebastián Matias |
author |
Jaworski, Juan Pablo |
author_facet |
Jaworski, Juan Pablo Vendrell, Alejandrina Chiavenna, Sebastián Matias |
author_role |
author |
author2 |
Vendrell, Alejandrina Chiavenna, Sebastián Matias |
author2_role |
author author |
dc.subject.none.fl_str_mv |
Virus de la Inmunodeficiencia Humana Anticuerpos Monoclonales Profilaxis de las Enfermedades Human Immunodeficiency Virus Monoclonal Antibodies Disease Prophylaxis |
topic |
Virus de la Inmunodeficiencia Humana Anticuerpos Monoclonales Profilaxis de las Enfermedades Human Immunodeficiency Virus Monoclonal Antibodies Disease Prophylaxis |
dc.description.none.fl_txt_mv |
Anti-human immunodeficiency virus type-1 (anti-HIV-1) neutralizing monoclonal antibodies are broadening the spectrum of pre- and post-exposure treatment against HIV-1. A better understanding of how these antibodies develop and interact with particular regions of the viral envelope protein is guiding a more rational structure-based immunogen design. The aim of this article is to review the most recent advances in the field, from the development of these particular antibodies during natural HIV-1 infection, to their role preventing infection, boosting endogenous immune responses and clearing both free viral particles and persistently infected cells. Inst.de Virología Fil: Jaworski, Juan Pablo. Instituto Nacional de Tecnología Agropecuaria (INTA). Instituto de Virología; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina Fil: Vendrell, Alejandrina. Universidad de Buenos Aires. Facultad de Medicina. Centro de Estudios Farmacológicos y Botánicos; Argentina Fil: Chiavenna, Sebastián Matias. Ferrer Advanced Biotherapeutics, Ferrer Internacional; España |
description |
Anti-human immunodeficiency virus type-1 (anti-HIV-1) neutralizing monoclonal antibodies are broadening the spectrum of pre- and post-exposure treatment against HIV-1. A better understanding of how these antibodies develop and interact with particular regions of the viral envelope protein is guiding a more rational structure-based immunogen design. The aim of this article is to review the most recent advances in the field, from the development of these particular antibodies during natural HIV-1 infection, to their role preventing infection, boosting endogenous immune responses and clearing both free viral particles and persistently infected cells. |
publishDate |
2017 |
dc.date.none.fl_str_mv |
2017 2018-03-09T14:28:17Z 2018-03-09T14:28:17Z |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
format |
article |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
http://hdl.handle.net/20.500.12123/2005 1664-3224 https://doi.org/10.3389/fimmu.2016.00661 https://www.frontiersin.org/articles/10.3389/fimmu.2016.00661/full |
url |
http://hdl.handle.net/20.500.12123/2005 https://doi.org/10.3389/fimmu.2016.00661 https://www.frontiersin.org/articles/10.3389/fimmu.2016.00661/full |
identifier_str_mv |
1664-3224 |
dc.language.none.fl_str_mv |
eng |
language |
eng |
dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess http://creativecommons.org/licenses/by-nc-sa/4.0/ Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
http://creativecommons.org/licenses/by-nc-sa/4.0/ Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) |
dc.format.none.fl_str_mv |
application/pdf |
dc.source.none.fl_str_mv |
Frontiers in immunology 7 : 661 (March 2017) reponame:INTA Digital (INTA) instname:Instituto Nacional de Tecnología Agropecuaria |
reponame_str |
INTA Digital (INTA) |
collection |
INTA Digital (INTA) |
instname_str |
Instituto Nacional de Tecnología Agropecuaria |
repository.name.fl_str_mv |
INTA Digital (INTA) - Instituto Nacional de Tecnología Agropecuaria |
repository.mail.fl_str_mv |
tripaldi.nicolas@inta.gob.ar |
_version_ |
1842341352969338880 |
score |
12.623145 |